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ABSTRACT
Metastasis to the cavernous sinus from head and neck cancer is uncommon and has been previously reported by a few 
authors. It is usually a late manifestation of the primary tumor and may be the first evidence of a widespread dissemi-
nation of the disease.
Main clinical findings are those related with involvement of cranial nerves III to VI as they pass through the cavernous 
sinus. Although diagnosis may be difficult, the appearance of clinical and radiological findings of cavernous sinus 
involvement in a context of head and neck cancer must alert us about an intracranial metastatic infiltration. In most 
cases treatment is palliative with radiotherapy and/or chemotherapy. The prognosis of this entity is poor, with survival 
of a few months.
We present the case of cavernous sinus metastasis from oropharyngeal squamous cell carcinoma and review the literature 
about the clinical presentation and management of this rare entity.  
Key words: Oral cancer, head and neck cancer, oropharyngeal cancer, squamous cell carcinoma, cavernous sinus, metasta-
sis.
RESUMEN
La metástasis al seno cavernoso procedente de carcinomas de cabeza y cuello es una rara entidad, que ha sido referida 
previamente por unos pocos autores. Normalmente es una manifestación tardía del tumor primario y puede ser la pri-
mera evidencia de una diseminación amplia de la enfermedad.
Los hallazgos clínicos fundamentales son aquellos relacionados con la afectación de los pares craneales III a VI, en su 
paso a través del seno cavernoso. Aunque el diagnóstico puede ser difícil, la presencia de hallazgos clínicos y radiológicos 
de afectación del seno cavernoso en un contexto de carcinoma de cabeza y cuello, debe alertar acerca de una infiltración 
metastática intracraneal. En la mayoría de los casos el tratamiento es paliativo con radioterapia y/o quimioterapia. El 
pronóstico de esta entidad es pobre, con supervivencia de unos pocos meses.
Presentamos un caso de metástasis de carcinoma epidermoide de orofaringe a nivel del seno cavernoso y realizamos una 
revisión de la literatura acerca de la presentación clínica y manejo de esta rara entidad.
Palabras clave: Cáncer oral, cáncer de cabeza y cuello, cáncer de orofarínge, carcinoma de células escamosas, seno caver-
noso, metástasis.
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INTRODUCTION
The appearance of  a local recurrence in head and neck 
cancer is not uncommon. Its correct management has been 
properly established in the literature. In contrast, involve-
ment of distant locations from a primary tumour of the head 
and neck continue being a problematic question, moreover 
if  an intracranial structure is implicated.
The affectation of the cavernous sinus (CS) from a tumour 
of  the head and neck has been reported by only a few 
authors, probably due to its infrequent presentation and 
misdiagnosed nature. The presence of distant metastasis 
within the maxillary bones have also been reported (1,2). 
The appearance of more precise imaging diagnostic tech-
niques have increased the number of reported cases in the 
last years (3-7). Since no direct extension from the primary 
tumour can be demonstrated, a metastatic nature of the CS 
involvement has to be considered.
Due to the existence of concomitant primary tumour, the 
surgical treatment of cavernous sinus metastasis (CSM) was 
not performed. Despite this, palliative management with 
radiotherapy and chemotherapy was performed, in order to 
avoid unnecessary morbidity and to obtain an improvement 
in quality of life.
CASE REPORT
A 64-year old man was referred to our Department with a 
left cervical mass and dysphagia in the past 2-3 months. In 
the physical examination there was a positive clinical neck, 
with a hard fixed node of 6x4 cm of diameter in left cervical 
level II, a hard mobile node of 1,5 cm of diameter in left 
cervical level III, and a hard fixed node of 5x3 cm in the right 
cervical level II. In the intraoral examination there was an 
exophytic and ulcerated lesion of the entire left tonsil, the 
left side of the uvula and extending to the vallecula, with a 
good mobilization of the tongue. 
A Computed Tomography (CT) of  head and neck was 
performed with the result of an increased mucosa of the 
left oropharyngeal space, with extension deeply into the 
parapharyngeal space. There were multiple cervical nodular 
images compatible with regional metastatic lymphatic nodes 
in left submandibular region and in left jugular chain and 
infiltrating common, internal and external carotid arteries. 
There were radiological positive nodes in level II and III 
of the right neck, with no infiltration of carotid arteries. 
Both jugular veins were collapsed and thrombosed. Both 
sternocleidomastoid muscles were infiltrated. 
A Fine-Needle-Aspiration (FNA) was performed and it 
was informed as suggestive of oropharyngeal squamous cell 
carcinoma (SCC). Then a biopsy was performed with the 
result of SCC poorly differentiated of the oropharynx. 
Due to the extension of the tumour, the surgical treatment 
was refused and radiotherapy was given in the oropharynx 
and cervical levels II, III and IV for 2 months with a total 
radiation of 7000 cGy. Simultaneously, chemotherapy with 
cisplatin firstly and taxol later were administered. 
Fig. 1. MRI. Coronal view. Tumoral mass in the 
left nasal cavity and ethmoidal cells as a cranial 
extension of the oropharyngeal SCC.
Fig 2,3,4. MRI. Coronal views. Engrossed right 
cavernous sinus suggesting mass compatible with 
metastasis from the primary tumor of the left 
oropharynx.
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A new CT was performed two months after the adminis-
tration of radiotherapy and chemotherapy with the result 
of probably residual metastatic nodes of 3 cm of diameter 
in cervical level II. The examination with fiberoscope did 
not show any disturbance in the tongue, lingual tonsil or 
vallecula, except for an edema in the epiglottis secondary to 
radiotherapy. A left radical neck dissection was then perfor-
med, after a balloon occlusion test of the left carotid artery 
and a cerebral arteriography were informed as normal. In 
the surgery it was extirpated the internal jugular vein, the 
spinalis nerve, and the common, internal and external caro-
tid arteries, but the vagus nerve was preserved. No carotid 
bypass was performed. In the histological study it was obser-
ved a salivary submandibular gland with no alterations and 
five lymphatic nodes of level I and II with no microscopic 
alterations, but partial reactive fibrosis.
Seven months after the surgery a new left supraclavicular 
metastatic node appeared and it was treated with excision 
and postsurgical radiotherapy with 4750 cGy for 3 months. 
After that, the patient presented progressive dyplopia with 
the right gaze. There was no tumour in the oral cavity or 
the oropharynx, and no lymphatic nodes were appreciated 
in the cervical region. A CT scan was performed, but no 
alterations were observed. Then, a Magnetic Resonance 
Imaging (MRI) was performed with the result of an enlarged 
right cavernous sinus with occupation of the left cavum, left 
pterigopalatine fosse and left nasal cavity and ethmoidal 
cells (Fig. 1,2,3,4). A biopsy of the cavum was informed 
as SCC of the nasopharynx. The diagnosis was regional 
recurrence of oropharyngeal SCC in the left nasopharynx, 
with extension to the left nasal cavity and ethmoidal cells, 
and metastasis of oropharyngeal SCC in the right cavernous 
sinus. Palliative radiotherapy was administered in the skull 
base and the left pterigopalatine fosse, with a total dose 
of  5700 cGy. Concomitant palliative chemotherapy was 
administered with cisplatine for 3 weeks. At the end of the 
treatment an improvement in diplopia was observed. Six 
months after the surgery the patient remains alive.
DISCUSSION
Intracranial metastasis from head and neck SCC are rarely 
clinically diagnosed. Furthermore metastasis to the CS 
from head and neck cancer are uncommon too (4,9,10). It 
has been reported in a variety of primary tumours of the 
Head and Neck area such as SCC of the larynx (7,10-12), 
melanoma of the head and neck (3), SCC of the head and 
neck (4,5,14), nasopharyngeal carcinoma (4), oropharyngeal 
carcinoma (4), carcinoma of the oral cavity (4), thyroid pa-
pillary adenocarcinoma (6), rhabdomyosarcoma of the head 
and neck (13), salivary duct carcinoma of minor salivary 
glands and SCC of salivary glands (7).
Clinical findings are those related with involvement of cra-
nial nerves III through VI as they pass the CS. Diplopia, 
ophthalmoplegia, decreased corneal reflex, dysesthesias, 
hypesthesia, headache, retroorbital pain and facial pain may 
be present (14). Our patient presented diplopia as a sign of 
an incipient affectation of the CS, with involvement of the 
abducens nerve. it is very interesting the frequent affectation 
of the cranial nerve VI, probably in relation with its more 
medial location in a reduced space such as the CS.   
The affectation of structures such as the trigeminal nerve 
may cause alteration of facial sensation. The presence of 
pain or dysesthesia can be explained by the infarction of 
the nerve caused by cancer cell involvement of the vasa 
nervorum (5).  Other symptoms such as ophthalmoplegia 
are in relation with lesions of cranial nerves III, IV and VI. 
Some metastatic tumours of the pituitary gland and the 
sellar region can involve cavernous sinus because of a lateral 
extension. Patients may present ptosis and diplopia, which 
are common in CSM. These symptoms can be associated 
with diabetes insipidus, because of the involvement of the 
posterior lobe of the pituitary gland. Our case presented 
diplopia with no other neuroendocrinologic disturbance, so 
a metastatic tumor of the pituitary gland was discarded. 
Perineural metastasis has been described as a pathological 
feature of head and neck cancers (5). CS involvement may 
also be present, with abducens nerve palsy. This symptom 
is similar as reported by us, but in our case the perineural 
spread was not demonstrated, due to the absence of any 
cranial nerve symptom before the diagnosis of CS invol-
vement was made. Instead of this, a vascular spread was 
thought to be the most probable cause of CS affectation 
in our patient. In relation to it, it is known that head and 
neck cancer situated in the proximity of  the upper two 
divisions of trigeminal nerve may affect the CS by direct 
extension, in contrast with other tumours of the head and 
neck which involve CS by haematogenous metastasis (14). 
In our patient both jugular veins were thrombosed and 
there was infiltration of left common, internal and external 
carotid arteries. This is another reason why haematogenous 
dissemination was thought to be the more probable cause 
of CS affectation.
CT and MRI are useful for diagnosis of involvement of CS 
by metastatic disease. It is typical for CT to reveal a contrast-
enhancing density in the parasellar region. Some authors 
(12)  advocate for the use of thin tomographic sections of 
5 mm or less, axial and coronal projections and large doses 
of intravenous contrast medium for the CS evaluation, to 
avoid a false-negative CT. Since MRI was introduced, a more 
acute diagnosis for CS lesions can be establish, due to its 
capacity for detection of solid masses of primary tumors 
or metastasis, and the presence of blood in cavernous sinus 
thrombosis (CST). In our case CT was not able to detect any 
abnormality, whereas MRI showed all the findings referred 
above. It is a well known finding for MRI to be more precise 
than CT for diagnosis of soft tissue disorders. 
In concordance with other authors (15)  we think that, in 
general, a suspected lesion of the CS with clinical and ra-
diological findings, in a context of tumoral disease, should 
be considered metastatic until proven otherwise. In relation 
to it we think that the performance of a biopsy through a 
transphenoidal (8) or subtemporal (4) approach could be 
the confirmatory diagnostic procedure, but often not per-
formed in the routine practice. In fact, few reports of CSM 
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are confirmed histopathologically. Surgical exploration of 
tumours in the CS has a high morbidity, so we preferred 
a diagnosis based in clinical findings and MRI to avoid 
additional damage.
An early diagnosis is fundamental for a proper management 
of the disease. The access of the tumor to the CS can be the 
first sign of a widespread dissemination. This is true in many 
cases, so a complete metastatic work-up with body-CT can 
be performed in order to determine the real extension of the 
disease. It is very important a correct differential diagnosis 
with other entities such as CST, carotid cavernous fistula, 
intracavernous carotid artery aneurysm, pituitary carcinoma 
and meningioma (16). Some authors (4)  advocate for the use 
of a computer assisted stereotatic navigation and stereotatic 
radiotherapy with diagnostic and/or treatment purposes.
The treatment of metastasis and CS involvement has been 
mostly palliative, with the use of  surgery, radiotherapy 
and chemotherapy. The trigeminal nerve section has been 
employed successfully in decreasing the facial pain (17). 
Radiotherapy has been the most frequently used treatment 
for CSM, with contrasted clinical improvement. It ranged 
from 2000 cGy to 8000 cGy in 10 to 30 fractions in the 
different works (11,14,17). Some authors (9) advocate for 
a more precise focused radiotherapy in the range of 6000 
to 7000 cGy. We administered 5700 cGy to the skull base 
and left pterigopalatine fosse, which is in the range of total 
dose administered by most authors, and we observed a 
clear relief  of symptoms with an improvement in patient´s 
quality of life. 
Combinations of surgery, radiotherapy and chemotherapy 
have been successful used in the control of the CS involve-
ment. Although we considered that there was not a curative 
treatment, a combination of radiotherapy and chemothe-
rapy was performed in a palliative manner. The value of 
chemotherapy for the treatment of CS involvement from 
solid tumours of the head and neck has not been properly 
established. Due to the concomitant use of cisplatine and 
radiotherapy we performed, it is difficult for us to judge 
properly the efficacy of chemotherapy alone. As reported 
by other authors (14), we did not employ surgery for the 
treatment of the lesion in CS, although some authors (6) 
consider the possibility of a direct surgical management in 
order to obtain a transient symptomatic relief  in extensive 
disease. Probably, surgical treatment may be performed 
when the primary tumour is under control. In cases of 
recurrence of the primary tumour and concomitant CSM, 
palliative management with radiotherapy and or chemo-
therapy may be indicated, moreover if  we consider that 
this entity is in many cases the first sign of a widespread 
tumoral dissemination.
The prognosis of this entity is poor, with survival of a few 
months. Moreover, it is known a 75% to 85% expected 
mortality within two years (9). This is why the treatment is 
palliative in the vast majority of the cases. Despite this, a 
median survival of 3 to 6 months has been referred (4) for 
patients treated with radiotherapy in contrast with mean 
survival of 1 month for untreated patients. There is not a 
clear prognostic factor, but some authors (4)  have found 
an association between the absence of active disease, the 
female sex and the age minor than 60 years with respect to 
an increased survival. Twelve months after the treatment 
our patient remains alive. This is more than the median 
survival, but follow-up is necessary to improve patients´ 
quality of life.
CONCLUSIONS
Cavernous sinus metastasis from oropharyngeal carcinoma 
is an extremely rare entity, which can be easily misdiagnosed. 
Clinical findings consisting in neurological disturbances 
related to cranial nerves III to VI, especially diplopia due 
to the affectation of abducens nerve, together with radio-
logical findings of  MRI, must make us to consider the 
existence of CS involvement in relation to metastasis of the 
primary tumour. Due to the oropharyngeal location of the 
primary tumour and the infiltration of cervical vessels in 
our patient, the haematogenous spread was though to be 
the most probable cause of CS affectation. This situation 
mostly implicates a widespread dissemination of the disease, 
with a poor prognosis. In cases of concomitant uncontrolled 
primary tumour we prefer to avoid any invasive diagnostic 
procedure such us the biopsy, due to the associated morbi-
dity. In most cases treatment is palliative with radiotherapy 
with or without chemotherapy.
REFERENCES
1. Alvarez-Alvarez C, Iglesias-Rodriguez B, Pazo-Irazu S, Delgado-San-
chez-Gracian C. Colonic adenocarcinoma with metastasis to the gingiva. 
Med Oral Patol Oral Cir Bucal 2006;11:E85-7. 
2. Sanchez-Jimenez J, Acebal-Blanco F, Arevalo-Arevalo RE, Molina-Mar-
tinez M. Metastatic tumours in upper maxillary bone of esophageal adeno-
carcinoma. A case report. Med Oral Patol Oral Cir Bucal 2005;10:252-7. 
3. Chang PC, Fischbein NJ, McCalmont TH, Kashani-Sabet M, Zettersten 
EM, Liu AY, et al. Perineural spread of malignant melanoma of the head 
and neck: clinical and imaging features. Am J Neuroradiol 2004;25:5-11.
4. de Bree R, Mehta DM, Snow GB, Quak JJ. Intracranial metastasis in 
patients with squamous cell carcinoma of the head and neck. Otolaryngol 
Head Neck Surg 2001;124:217-21.
5. Zhu JJ, Padillo O, Duff J, His BL, Fletcher JA, Querfurth H. Cavernous 
sinus and leptomeningeal metastasis arising from a squamous carcinoma 
of the face: case report. Neurosurgery 2004;54:492-8.
6. Takami TM, Ohata k, Tsuyuguchi N, Mao Y, Inoue Y, Wakasa K, et 
al. Cavernous sinus metastasis from thyroid papillary adenocarcinoma. J 
Clin Neurosci 2002;9:598-600.
7. Urban SD, Hall JM, Bentkover SH, Kadish SP. Salivary duct carcinoma 
of minor salivary gland origin: report of a case involving the cavernous 
sinus. J Oral Maxillofac Surg 2002;60:958-62.
8. Curry MP, Newlon JL, Watson Dw. Cavernous sinus metastasis 
from laryngeal squamous cell carcinoma. Otolaryngol Head Neck Surg 
2001;125:567-8.
9. Rosenfeld DJ, Berenholz L, Glasgold M, Rao V, Spiegel J. Malignant 
neoplasms of the sphenoid sinus. Transactions Trans Pa Acad Ophthalmol 
Otolaryngol.  1987;39:618-21.
10. Kattah JC, Silgals RM, Manz H, Toro JG, Dritschilo A, Smith FP. 
Presentation and management of parasellar and suprasellar metastatic 
mass lesions. J Neurol Neurosurg Psychiatry 1985;48:44-9. 
11. Zahra M, Tewfik HH, McCabe BF. Metastasis to the cavernous sinus 
from primary carcinoma of the larynx. J Surg Oncol 1986;31:69-70.
12. Morales AC, González-Rodilla I, del Valle Zapico A. Sphenoid metas-
tasis of laryngeal carcinoma (Spanish). Acta Otol Esp 1994;45:287-9.
13. Reynard M, Brinkley JR Jr. Cavernous sinus syndrome caused by 
rhabdomyosarcoma. Ann Ophthalmol 1983;15:94-7.
E170
Med Oral Patol Oral Cir Bucal 2007;12:E166-70.                                                                                   � Metastasis in cavernous sinus                                                       Med Oral Patol Oral Cir Bucal 2007;12:E166-70.                                                                               � Metastasis in cavernous sinus    
14. Bumpous JM, Maves MD, Gómez SM, Levy BK, Johnson F. Cavernous 
sinus involvement in head and neck cancer. Head Neck 1993;15:62-6. 
15. Van Wart CA, Dedo HM, McCoy EG. Carcinoma of sphenoid sinus. 
Ann Otol 1973;82:318-22.
16. Traserra J, Comas J, Conde C, Cuchi A, Cardesa A. Metastaic invol-
vement of the cavernous sinus from primary pharyngolaryngeal tumors. 
Head Neck 1990;12:426-9.
17. Bitoh S, Hasegawa H, Ohtsuki H, Ohtsuki H, Yamamoto T. Parasellar 
metastasis: four autopsied cases. Surg Neurol 1985;23:41-8.
